Challenges of Anticoagulation Management Service and Need of Establishing Pharmacist-Led Anticoagulation Clinic in Tertiary Care Teaching Hospital, Ethiopia: A Qualitative Study

References

• Anderson DR, Morgano GP, Bennett C, et al. American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients. Blood Adv. 2019;3(23):3898–3944. doi:10.1182/bloodadvances.2019000975
   PubMed Web of Science ®Google Scholar
• Testa S, Paoletti O, Zimmermann A, Bassi L, Zambelli S, Cancellieri E. The role of anticoagulation clinics in the era of new oral anticoagulants. Thrombosis. 2012;2012(1). doi:10.1155/2012/835356
   PubMedGoogle Scholar
• Hirsh J, Guyatt GH. Executive summary: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133. doi:10.1378/chest.08-0693
   Web of Science ®Google Scholar
• Platt AB, Localio AR, Brensinger CM, et al. Risk factors for nonadherence to warfarin: results from the IN-RANGE study. Pharmacoepidemiol Drug Saf. 2008;17:853–860. doi:10.1002/pds
   PubMed Web of Science ®Google Scholar
• Hou K, Yang H, Ye Z, Wang Y, Liu L, Cui X. Effectiveness of pharmacist-led ANTICOAGULATION management on clinical outcomes: a systematic review and meta-analysis. J Pharm Pharm Sci. 2017;2017:378–396.
   Google Scholar
• Witt DM, Clark NP, Kaatz S, Schnurr T, Ansell JE. Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism. J Thromb Thrombolys. 2016;41(1):187–205. doi:10.1007/s11239-015-1319-y
   PubMed Web of Science ®Google Scholar
• Greenblatt DJ, Von Moltke LL. Interaction of warfarin with drugs, natural substances, and foods. J Clin Pharmacol. 2005;45(2):127–132. doi:10.1177/0091270004271404
   PubMed Web of Science ®Google Scholar
• Elewa HF, AbdelSamad O, Elmubark AE, et al. The first pharmacist-managed anticoagulation clinic under a collaborative practice agreement in Qatar: clinical and patient-oriented outcomes. J Clin Pharm Ther. 2016;41(4):403–408. doi:10.1111/jcpt.12400
   PubMed Web of Science ®Google Scholar
• Lakshmi R, James E, Kirthivasan R. Study on impact of clinical pharmacist’s interventions in the optimal use of oral anticoagulants in stroke patients. Indian J Pharm Sci. 2013;75(1):53–59. doi:10.4103/0250-474X.113550
   PubMed Web of Science ®Google Scholar
• Bungard TJ, Gardner L, Archer SL, et al. Evaluation of a pharmacist-managed anticoagulation clinic: improving patient care. Open Med. 2009;3(1):16–21.
   Google Scholar
• Ingram SJ, Kirkdale CL, Williams S, et al. Moving anticoagulation initiation and monitoring services into the community: evaluation of the Brighton and hove community pharmacy service. BMC Health Serv Res. 2018;18(1):1–7. doi:10.1186/s12913-018-2901-8
   PubMed Web of Science ®Google Scholar
• Young S, Bishop L, Twells L, Dillon C, Hawboldt J, Shea PO. Comparison of pharmacist-managed anticoagulation with usual medical care in a family medicine clinic. BMC Family Practice. 201112:88:1-7 doi:10.1186/1471-2296-12-88.
   Google Scholar
• Aidit S, Soh YC, Yap CS, et al. Effect of standardized warfarin treatment protocol on anticoagulant effect: comparison of a warfarin medication therapy adherence clinic with usual medical care. Front Pharmacol. 2017;8:1–9. doi:10.3389/fphar.2017.00637
   PubMed Web of Science ®Google Scholar
• Teklay G, Shiferaw N, Legesse B, Bekele ML. Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study. Thromb J. 2014;12(1):1–8. doi:10.1186/1477-9560-12-20
   PubMedGoogle Scholar
• Fenta TG, Assefa T, Alemayehu B. Quality of anticoagulation management with warfarin among outpatients in a tertiary hospital in Addis Ababa, Ethiopia: a retrospective cross-sectional study. BMC Health Serv Res. 2017;17(1):1–7. doi:10.1186/s12913-017-2330-0
   PubMed Web of Science ®Google Scholar
• Assefa T, Gedif T, Alemayehu B. Evaluation of patients ‘ knowledge on warfarin therapy among outpatients receiving warfarin at Tikur Anbessa specialized. Ethiop Pharm J. 2014;138:133–138.
   Google Scholar
• Dejene F, Berihun D, Assefa T. Healthcare professionals’ knowledge and counseling practice on warfarin therapy at tertiary care teaching hospital, Addis Ababa, Ethiopia. Cardiovasc Pharmacol Open Access. 2017;06(1):1–6. doi:10.4172/2329-6607.1000206
   Google Scholar
• Ahmed F, Hussen S, Assefa T. Venous thromboembolism risk, prophylaxis and outcome in hospitalized patients to medical wards of university teaching hospital. J Clin Exp Cardiolog. 2019;10(1):13–15. doi:10.4172/2155-9880.1000620
   Google Scholar
• Tadesse TA, Kedir HM, Fentie AM, Abiye AA. Venous thromboembolism risk and thromboprophylaxis assessment in surgical patients based on caprini risk assessment model. Risk Manag Healthc Policy. 2020;13:2545–2552. doi:10.2147/RMHP.S272852
   PubMed Web of Science ®Google Scholar
• Anakwue RC. Anticoagulation in sub Saharan Africa with the advent of non vitamin k antagonist oral anticoagulants. Niger J Med. 2020. doi:10.4103/NJM.NJM
   Google Scholar
• Mouton J, Blockman M, Sekaggya-wiltshire C, et al. Improving anticoagulation in sub-Saharan Africa – what are the challenges, and how can we overcome them? Br J Clin Pharmacol. 2020;87:1–17.
   Web of Science ®Google Scholar
• Falamić S, Lucijanić M, Hadžiabdić MO, Marušić S, Bačić Vrca V. Pharmacist’s interventions improve time in therapeutic range of elderly rural patients on warfarin therapy: a randomized trial. Int J Clin Pharm. 2018. doi:10.1007/s11096-018-0691-z
   PubMed Web of Science ®Google Scholar
• Falamić S, Lucijanić M, Ortner M, Srećko H, Vesna M, Vrca B. Pharmacist‘s influence on adverse reactions to warfarin: a randomised controlled trial in elderly rural patients. Int J Clin Pharm. 2019. doi:10.1007/s11096-019-00894-4
   PubMed Web of Science ®Google Scholar
• Falamić S, Lucijanić M, Hadžiabdić MO, Marušić S. Pharmacist‘s interventions improve health ‑ related quality of life of rural older person on warfarin: a randomized controlled trial. Sci Rep. 2021;1–7. doi:10.1038/s41598-021-01394-0
   PubMed Web of Science ®Google Scholar
• Chen S-L, Rose AE. Anticoagulation stewardship. Anticoagulation Manag. 2015;249–274. doi:10.1007/978-3-319-22602-6_11
   Google Scholar
• Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016;149(2):315–352. doi:10.1016/j.chest.2015.11.026
   PubMed Web of Science ®Google Scholar
• Nwagha T. A survey of clinicians practice patterns in anticoagulation therapy & prophylaxis in Nigeria. Haematol Int J. 2018;2(3):1–8. doi:10.23880/hij-16000125
   Google Scholar
• Medical Advisory Secretariat. Point-of-care international normalized ratio (INR) monitoring devices for patients on long-term oral anticoagulation therapy: an evidence-based analysis. Ont Health Technol Assess Ser. 2009;9:1.
   Google Scholar
• Kimmel SE, Chen Z, Price M, et al. The influence of patient adherence on anticoagulation control with warfarin: results from the international normalized ratio adherence and genetics (IN-RANGE) study. Arch Intern Med. 2007;167(3):229–235. doi:10.1001/archinte.167.3.229
   PubMed Web of Science ®Google Scholar
• Witt DM, Nieuwlaat R, Clark NP, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy. Blood Adv. 2018;2(22):3257–3291. doi:10.1182/bloodadvances.2018024893
   PubMed Web of Science ®Google Scholar
• Barnes G, Haymart B, Alexandris-Souphis T. Anticoagulation Desktop Reference (Version 2.4). Blue Cross and Blue Shield Association; 2020.
   Google Scholar
• Wigle P, Hein B, Bloomfield HE, Tubb M, Doherty M. Updated guidelines on outpatient anticoagulation. Am Fam Physician. 2013;87(8):556–566.
   PubMed Web of Science ®Google Scholar
• January CT, Wann LS, Calkins H, et al.2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. J Am Coll Cardiol. 2019;74(1). doi:10.1016/j.jacc.2019.01.011
   PubMed Web of Science ®Google Scholar
• Holbrook A, Schulman S, Witt DM, et al. Evidence-based management of anticoagulant therapy. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2SUPPL):e152S–e184S.
   PubMed Web of Science ®Google Scholar
• Health Q. Guidelines for warfarin management in the community guidelines for warfarin management in the community guidelines for warfarin management in the community -iii. Dep Heal. 2016;201:1–27.
   Google Scholar
• Queensland Government. Guidelines for anticoagulation using warfarin – adult. 2015:4–5.
   Google Scholar
• Anticoagulation Forum. Anticoagulation stewardship programs. 2019.
   Google Scholar
• Ebrahim I, Bryer A, Cohen K, Mouton JP, Msemburi W, Blockman M. Poor anticoagulation control in patients taking warfarin at a tertiary and district-level prothrombin clinic in Cape Town, South Africa. South African Med J. 2018;108(6):490–494. doi:10.7196/SAMJ.2018.v108i6.13062
   PubMed Web of Science ®Google Scholar
• Alghadeeer S, Alzahrani AA, Alalayet WY, Alkharashi AA, Alarifi MN. Anticoagulation control of warfarin in pharmacist-led clinics versus physician-led clinics: a prospective observational study. Risk Manag Healthc Policy. 2020;13:1175–1179. doi:10.2147/RMHP.S248222
   PubMed Web of Science ®Google Scholar
• Ahmed NO, Osman B, Abdelhai YM, El-Hadiyah TMH. Impact of clinical pharmacist intervention in anticoagulation clinic in Sudan. Int J Clin Pharm. 2017;39(4):769–773. doi:10.1007/s11096-017-0475-x
   PubMed Web of Science ®Google Scholar
• Jiawen H, Zhidong Z, Chengfeng H, Xiaohui LI, Xiaoshen Z, Hua LU. Pharmacist-led anticoagulation monitoring can significantly improve the effectiveness and safety of warfarin for patients during hospitalization. J South Med Univ. 2020;40(4):544–549. doi:10.12122/j.issn.1673-4254.2020.04.15
   Google Scholar
• Saokaew S, Sapoo U, Nathisuwan S, Chaiyakunapruk N, Permsuwan U. Anticoagulation control of pharmacist-managed collaborative care versus usual care in Thailand. Int J Clin Pharm. 2012;34(1):105–112. doi:10.1007/s11096-011-9597-8
   PubMed Web of Science ®Google Scholar
• Yamada K, Nabeshima T. Pharmacist-managed clinics for patient education and counseling in Japan: current status and future perspectives. J Pharm Heal Care Sci. 2015;1(1):1–8. doi:10.1186/s40780-014-0001-4
   PubMedGoogle Scholar